| scholarly article | Q13442814 |
| P356 | DOI | 10.1248/BPB.18.1145 |
| P698 | PubMed publication ID | 8535413 |
| P2093 | author name string | Sato T | |
| Asakawa N | |||
| Nochi S | |||
| P433 | issue | 8 | |
| P304 | page(s) | 1145-1147 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Biological and Pharmaceutical Bulletin | Q15754240 |
| P1476 | title | Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020). | |
| P478 | volume | 18 |
| Q48244513 | A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. |
| Q43923751 | A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia |
| Q37043396 | ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy. |
| Q43782883 | Acetyl and butyrylcholinesterase-inhibiting triterpenoid alkaloids from Buxus papillosa |
| Q46163580 | Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease |
| Q41998948 | Anticholinesterase and Antioxidative Properties of Aqueous Extract of Cola acuminata Seed In Vitro. |
| Q44658338 | Aromatic amino‐acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept®) to cholinesterases |
| Q91962778 | Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones |
| Q53333243 | Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. |
| Q92347314 | Chromenones as Multineurotargeting Inhibitors of Human Enzymes |
| Q42208055 | Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses |
| Q34755454 | Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses |
| Q43509016 | Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor |
| Q41435362 | Donepezil |
| Q36179666 | Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease |
| Q42495563 | Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain |
| Q34519657 | Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles. |
| Q34965949 | Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics |
| Q33914241 | Donepezil: a review of its use in Alzheimer's disease |
| Q55316497 | HPLC-DAD fingerprinting analysis, antioxidant activities of Tithonia diversifolia (Hemsl.) A. Gray leaves and its inhibition of key enzymes linked to Alzheimer's disease. |
| Q84969941 | Hyperbolic mixed-type inhibition of acetylcholinesterase by tetracyclic thienopyrimidines |
| Q46595750 | In vitro enzyme inhibition activities of crude ethanolic extracts derived from medicinal plants of Pakistan |
| Q46085377 | Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile |
| Q44340367 | Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors |
| Q26744105 | Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease |
| Q60907928 | Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors |
| Q44555583 | Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine |
| Q38208461 | Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease |
| Q37208415 | Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP) |
| Q28370930 | SCH 57790: a novel M2 receptor selective antagonist |
| Q43891629 | Substituted 2-(R)-methyl piperazines as muscarinic M(2) selective ligands |
| Q73212109 | Territrem B, a tremorgenic mycotoxin that inhibits acetylcholinesterase with a noncovalent yet irreversible binding mechanism |
| Q22242019 | The cholinergic hypothesis of Alzheimer's disease: a review of progress |
| Q26995817 | The pharmacological landscape and therapeutic potential of serine hydrolases |
| Q34078785 | Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples |
Search more.